作者：
Shuo,Feng [1]
;
Daniel J.,Phillips [2]
;
Thomas,White [3]
;
Homesh,Sayal [4]
;
Parvinder K.,Aley [5]
;
Sagida,Bibi [6]
;
Christina,Dold ;
Michelle,Fuskova ;
Sarah C.,Gilbert ;
Ian,Hirsch ;
Holly E.,Humphries ;
Brett,Jepson ;
Elizabeth J.,Kelly ;
Emma,Plested ;
Kathryn,Shoemaker ;
Kelly M.,Thomas ;
Johan,Vekemans ;
Tonya L.,Villafana ;
Teresa,Lambe ;
Andrew J.,Pollard ;
Merryn,Voysey
作者单位：
National Infection Service,Public Health England
[1]
Late-stage development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D,AstraZeneca
[2]
Oxford Vaccine Group, Department of Paediatrics,University of Oxford
[3]
Late-stage development Respiratory and Immunology (R&I), BioPharmaceuticals R&D,AstraZeneca
[4]
Microbial Sciences, BioPharmaceuticals R&D,AstraZeneca
[5]
The Jenner Institute, Nuffield Department of Medicine,University of Oxford
[6]
发布时间
2022-03-21
换一批
